Clinical Phase III study finalized with GMP-compliant Zr-89 from BV Cyclotron VU, Amsterdam

Congratulations Telix on the positive results of your Phase III study. We are glad that we were able to participate in this study.

For the full message of Telix: https://telixpharma.com/news-views/zircon-phase-iii-top-line-data-study-meets-primary-objectives/